Analysis on distribution characteristics and drug resistance of Klebsiella pneumoniae in a hospital during 2011-2015
10.3969/j.issn.1673-4130.2016.23.008
- VernacularTitle:2011～2015年某院肺炎克雷伯菌的分布特点及耐药性分析
- Author:
Yanghui QIAN
;
Xiaole LI
;
Yanjun LI
;
Xiuhong HAO
;
Yiwei DING
;
Peipei DING
;
Jiaoxian WANG
;
Qiangyuan ZHAO
- Keywords:
Klebsiella pneumonia;
antimicrobial resistance;
antimicrobial agents;
carbapenemases
- From:
International Journal of Laboratory Medicine
2016;37(23):3260-3262
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the clinical distribution situation and drug resistance change of Klebsiella pneumoniae in the Navy General Hospital during 2011‐2015 in order to provide reference for rational use of antibacterial agents in clinic .Methods The clinically isolated Klebsiella pneumoniae in this hospital during 2011‐2015 were selected and performed the analysis on the de‐tection rate ,department distribution ,specimens source ,resistance of antibacterial drugs and change trend of resistance to carbapen‐em antibacterial drugs .Results The number the detected Klebsiella pneumoniae strains and isolation rate during 2011 -2015 showed an increasing trend year by year ,the specimens sources were mainly from 10 departments of intensive care units(ICU) ,hy‐perbaric oxygen department ,respiratory department ,radiation oncology department ,kidney disease department ,etc .;the submitted specimens were dominated by sputum and urine ,accounting for 59 .7% and 21 .4% of submitted specimens ;the drug resistance of Klebsiella pneumoniae during 2011‐2015 showed the increasing trend year by year .Klebsiella pneumoniae had higher resistance rates to piperacillin ,ampicillin ,ampicillin/sulbactam and cefuroxime and had lower resistance rate to amikacin ,imipenem ,meropen‐em and tobramycin ;the resistance rates to imipenem and meropenem were increased year by year ,and pan‐drug resistant Klebsiella pneumoniae showed a rapidly rising trend .Conclusion The drug resistance of Klebsiella pneumonia is serious ,especially carbapene‐ms‐resistant Klebsiella pneumoniae is significantly increased in the recent years ,therefore its drug resistance monitoring should be strengthened for guiding rational drug use in clinic .
